Epilepsy and Marijuana: Safety and Treatment Recommendations
For epilepsy treatment, avoid recreational marijuana entirely and use only FDA-approved pharmaceutical-grade cannabidiol (Epidiolex) under medical supervision, as THC-containing products may worsen seizure control and interact dangerously with antiseizure medications.
Key Recommendation: Use FDA-Approved CBD Only
The only safe and evidence-based approach is pharmaceutical-grade CBD (Epidiolex), which is FDA-approved specifically for certain epilepsy syndromes 1. This is the only CBD product that has undergone rigorous clinical trials and received FDA approval as of 2024 1.
Why Avoid Recreational Marijuana and Artisanal CBD Products
- THC is problematic: THC has "high potential for misuse" and may actually trigger breakthrough seizures in patients with epilepsy 1, 2
- Unregulated products are dangerous: Artisanal CBD products from dispensaries lack quality control, have unknown concentrations, and may contain harmful contaminants 3
- Recent case evidence: Two 2025 case reports documented that cannabis use (containing THC) was temporally associated with breakthrough seizures and poor seizure control in patients with focal epilepsy, even those using responsive neurostimulation 2
FDA-Approved Indications for Epidiolex
Epidiolex is approved for:
- Lennox-Gastaut syndrome (approved 2018)
- Dravet syndrome (approved 2018)
- Tuberous sclerosis complex (approved 2020)
Dosing Protocol for Epidiolex
Based on Phase 3 randomized controlled trials 4, 3:
- Starting dose: Begin at lower end of therapeutic range
- Therapeutic doses: 10-20 mg/kg/day divided into two doses
- Efficacy data:
Critical Safety Considerations
Drug Interactions (Major Concern)
CBD significantly interacts with common antiseizure medications 5:
- Clobazam: CBD inhibits CYP2C19, dramatically increasing levels of N-desmethylclobazam (active metabolite), causing excessive sedation 5
- Valproate: Combination increases risk of liver enzyme elevations (AST/ALT) 5
- Other interactions: Possible effects on rufinamide, zonisamide, topiramate, eslicarbazepine levels 5
- Warfarin: Requires dose adjustment with concomitant CBD 5
Common Adverse Events
From pooled trial data 4:
- Somnolence (especially with clobazam)
- Decreased appetite
- Diarrhea
- Elevated liver enzymes (particularly with valproate)
Treatment discontinuation: 8.9% stopped CBD due to adverse events vs 1.8% on placebo, with the 20 mg/kg/day dose having higher discontinuation rates 4
Evidence Quality Assessment
Strong Evidence (Use This)
- Randomized controlled trials for Dravet and Lennox-Gastaut syndromes show clear efficacy 4, 3
- FDA approval based on rigorous Phase 3 data 1
Weak/Conflicting Evidence (Ignore This)
- A 2022 observational study of low-dose CBD:THC combinations (1:20 and 1:50 ratios, max 6mg THC/day) found no evidence of efficacy for seizure reduction, duration, or rescue medication use 6
- Artisanal products have only anecdotal/survey data without controlled dosing 5, 3
Clinical Algorithm
Step 1: Determine if patient has FDA-approved indication (Lennox-Gastaut, Dravet, tuberous sclerosis)
- Yes → Consider Epidiolex with neurologist consultation
- No → Epidiolex may still help based on emerging data for other treatment-resistant epilepsies 7, but use only under specialist care
Step 2: Review current antiseizure medications
- On clobazam or valproate → Expect interactions; monitor closely for sedation and liver enzymes
- On warfarin → Plan for dose adjustments
Step 3: Counsel patient explicitly
- Avoid all THC-containing products - may worsen seizures 2
- Avoid dispensary/online CBD - unregulated and potentially harmful
- Use only pharmaceutical-grade Epidiolex
Step 4: Monitor
- Baseline and periodic liver function tests (especially with valproate)
- Sedation levels (especially with clobazam)
- Seizure frequency and severity
Critical Pitfalls to Avoid
- Never recommend recreational marijuana or "medical marijuana" from dispensaries - these contain variable THC that may trigger seizures 2
- Don't assume all CBD is the same - only Epidiolex has proven safety/efficacy data 1
- Don't overlook drug interactions - CBD is a potent CYP2C19 inhibitor requiring medication adjustments 5
- Don't use in pregnancy - FDA and Surgeon General advise against all cannabis/CBD products due to fetal brain development risks 1
Bottom Line
The only cannabinoid product with established safety and efficacy for epilepsy is pharmaceutical-grade CBD (Epidiolex) at 10-20 mg/kg/day for specific epilepsy syndromes 1, 4. All THC-containing products should be avoided as they may worsen seizure control 2. Artisanal CBD products lack quality control and evidence 3. Close monitoring for drug interactions and adverse effects is mandatory 5.